Dyadic International Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.72

-0.04 (-5.52%)

As of May 16, 2:24 AM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +4,407.0% upside

Low Target $20.70

Average Target $32.64

High Target $34.69

Current Price $0.72

Current
$0.72

Target
$32.64

$20.70 $32.64 avg $34.69

Scenario Analysis

Bear Case

$20.70

2,758.3%

Low target

Base Case

$32.64

+4,407.0%

Avg target

Bull Case

$34.69

+4,690.1%

High target

Risk/Reward

1.7x

Balanced

Price in Context

52-Week High

$1.35

-46.2% from high

52-Week Low

$0.65

+10.6% from low

Target vs 52W High

$32.64

+2,325.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+22.4%
AMGN Amgen Inc	Hold	44	48%	$190.87	-41.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+179.9%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+0.3%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.0%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-64.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-21.7%
BIIB Biogen Inc	Buy	43	56%	$91.45	-52.6%